How can we prevent neuronal apoptosis?

Neuronal Cell Apoptosis

Volumn , Issue , 2011, Pages 167-189

  Doherty, G H ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856045164     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (126)

1. Alenzi FQ, Lotfy M, Wyse R., 2010, Swords of cell death: caspase activation and regulation. Asian Pac. J. Cancer Prev., 11(2):271-80.
2. Aoi M, Date I, Tomita S, Ohmoto T., 2000, Single or continuous injection of glial cell line-derived neurotrophic factor in the striatum induces recovery of the nigrostriatal dopaminergic system. Neurol. Res, 22(8):832-6.
3. Arai Y, Sekine Y, Murakami S., 1996, Estrogen and apoptosis in the developing sexually dimorphic preoptic area in female rats. Neurosci. Res., 25(4):403-7.
4. Ashkenazi A, Dixit VM., 1998, Death receptors: signaling and modulation. Science., 281(5381):1305-8.
5. Bahmanyar S, Higgins GA, Goldgaber D, Lewis DA, Morrison JH, Wilson MC, Shankar SK, Gajdusek DC., 1987, Localization of amyloid beta protein messenger RNA in brains from patients with Alzheimer's disease. Science., 237(4810):77-80.
6. Barbin G, Manthorpe M, Varon S., 1984, Purification of the chick eye ciliary neuronotrophic factor. J. Neurochem., 43(5):1468-78.
7. Barde YA, Edgar D, Thoenen H., 1982, Purification of a new neurotrophic factor from mammalian brain. EMBO J., 1(5):549-53.
8. Barker RA, Dunnett SB, Faissner A, Fawcett JW., 1996, The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum. Exp. Neurol., 141(1):79-93
9. Barker V, Middleton G, Davey F, Davies AM., 2001, TNFα contributes to the death of NGF-dependent neurons during development. Nature Neuroscience 4(12), 1194-1198
10. Barres BA, Schmid R, Sendnter M, Raff MC., 1993, Multiple extracellular signals are required for long-term oligodendrocyte survival. Development., 118(1):283-95.
11. Behl C, Davis JB, Klier FG, Schubert D., 1994, Amyloid beta peptide induces necrosis rather than apoptosis. Brain Res., 645(1-2):253-64.
12. Benisty S, Boissiere F, Faucheux B, Agid Y, Hirsch EC., 1998, trkB messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients: an in situ hybridization study. Neuroscience., 86(3):813-26.
13. Bennet JP., 1988, Biochemical pathology and pharmacology of Parkinson's disease. In: Stern MB, Hurtig HI, (eds.) The comprehensive management of Parkinson's disease. New York: PMA Publishing, 63-76.
14. Berkemeier LR, Winslow JW, Kaplan DR, Nikolics K, Goeddel DV, Rosenthal A., 1991, Neurotrophin-5: a novel neurotrophic factor that activates trk and trkB. Neuron., 7(5):857-66.
15. Bilsland J, Roy S, Xanthoudakis S, Nicholson DW, Han Y, Grimm E, Hefti F, Harper SJ., 2002, Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons. J. Neurosci., 22(7):2637-49.
16. Brann DW, Dhandapani K, Wakade C, Mahesh VB, Khan MM., 2007, Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications. Steroids., 72(5):381-405.
17. Bunone G, Mariotti A, Compagni A, Morandi E, Della Valle G., 1997, Induction of apoptosis by p75 neurotrophin receptor in human neuroblastoma cells. Oncogene. 1997, 14(12):1463-70.
18. Catsicas S, Thanos S, Clarke PG., 1987, Major role for neuronal death during brain development: refinement of topographical connections. Proc. Natl. Acad. Sci. USA, 84(22):8165-8.
19. Chu CT., 2006, Autophagic stress in neuronal injury and disease., J. Neuropathol. Exp. Neurol., 65(5):423-32.
20. Cohen S, 1960, Purification of nerve growth factor-promoting protein from the mouse salivary gland and its neurocytotoxic antiserum. Proc. Natl. Acad. Sci. USA., 46: 302-311.
21. Coleman ML, Sahai EA, Yeo M, Bosch M, Dewar A, Olson MF., 2001, Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat. Cell Biol., 3(4):339-45.
22. Cuervo AM., 2004, Autophagy: many paths to the same end. Mol. Cell Biochem. 2004, 263(1-2):55-72.
23. Cunningham RL, Giuffrida A, Roberts JL., 2009, Androgens induce dopaminergic neurotoxi-city via caspase-3-dependent activation of protein kinase Cdelta. Endocrinology., 150(12):5539-48.
24. Cutillas B, Espejo M, Gil J, Ferrer I, Ambrosio S., 1999, Caspase inhibition protects nigral neurons against 6-OHDA-induced retrograde degeneration. Neuroreport., 10(12):2605-8.
25. Davis EC, Shryne JE, Gorski RA., 1995, A revised critical period for the sexual differentiation of the sexually dimorphic nucleus of the preoptic area in the rat. Neuroendocrinology., 62(6):579-85.
26. Delabar JM, Goldgaber D, Lamour Y, Nicole A, Huret JL, de Grouchy J, Brown P, Gajdusek DC, Sinet PM., 1987, Beta amyloid gene duplication in Alzheimer's disease and karyotypically normal Down syndrome. Science., 235(4794):1390-2.
27. Doherty G., 2007, Developmental switch in the effects of TNFα on dopaminergic midbrain neurons. Neuroscience Research, 57, 296-305.
28. Eriksdotter Jönhagen M, Nordberg A, Amberla K, Bäckman L, Ebendal T, Meyerson B, Olson L, Seiger, Shigeta M, Theodorsson E, Viitanen M, Winblad B, Wahlund LO., 1998, Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease., Dement. Geriatr. Cogn. Disord., 9(5):246-57.
29. Fei Q, McCormack AL, Di Monte DA, Ethell DW., 2008, Paraquat neurotoxicity is mediated by a Bak-dependent mechanism. J. Biol. Chem., 283(6):3357-64.
30. Foister NS, Oldreive CE, Mackie JB, Doherty GH., 2005, Embryonic cerebellar granule cells are resistant to necrosis induced by homocysteine. Brain Res. Dev. Brain Res., 160(1):85-9.
31. Gibrat C, Bousquet M, Saint-Pierre M, Lévesque D, Calon F, Rouillard C, Cicchetti F., 2010, Cystamine prevents MPTP-induced toxicity in young adult mice via the up-regulation of the brain-derived neurotrophic factor. Prog. Neuropsychopharmacol. Biol. Psychiatry., 34(1):193-203.
32. Gill SS, Patel NK, Hotton GR, O'Sullivan K, McCarter R, Bunnage M, Brooks DJ, Svendsen CN, Heywood P., 2003, Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat. Med., 9(5):589-95.
33. Gilmore EC, Nowakowski RS, Caviness VS Jr, Herrup K. 2000. Cell birth, cell death, cell diversity and DNA breaks: how do they all fit together? Trends Neurosci., 23(3):100-5.
34. Glenner GG, Wong CW., 1984, Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun., 120(3):885-90.
35. Glucksmann A, 1951, Cell death in normal vertebrate ontogeny. Biol. Rev., 26:59-86.
36. Gyárfás T, Knuuttila J, Lindholm P, Rantamäki T, Castrén E., 2010, Regulation of brain-derived neurotrophic factor (BDNF) and cerebral dopamine neurotrophic factor (CDNF) by anti-parkinsonian drug therapy in vivo. Cell Mol. Neurobiol., 30(3):361-8.
37. Hallböök F, Ibáñez CF, Persson H., 1991, Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary. Neuron., 6(5):845-58.
38. Hamburger V, Levi-Montalcini R., 1949, Proliferation, differentiation and degeneration in the spinal ganglia of the chick embryo under normal and experimental conditions. J. Exp. Zool., 111(3):457-501
39. Hartmann A, Hunot S, Michel PP, Muriel MP, Vyas S, Faucheux BA, Mouatt-Prigent A, Turmel H, Srinivasan A, Ruberg M, Evan GI, Agid Y, Hirsch EC., 2000, Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc. Natl. Acad. Sci. USA, 97(6):2875-80.
40. Hartmann A, Troadec JD, Hunot S, Kikly K, Faucheux BA, Mouatt-Prigent A, Ruberg M, Agid Y, Hirsch EC., 2001, Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis. J. Neurosci., 21(7):2247-55.
41. Hefti F., 1986, Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections., J. Neurosci., 6(8):2155-62.
42. Hellweg R, Jockers-Scherübl M., 1994, Neurotrophic factors in memory disorders. Life Sci., 55(25-26):2165-9.
43. Helt CE, Hoernig GR, Albeck DS, Gerhardt GA, Ickes B, Reyland ME, Quissell DO, Strömberg I, Granholm AC., 2001, Neuroprotection of grafted neurons with a GDNF/caspase inhibitor cocktail. Exp. Neurol, 170(2):258-69.
44. Higgins GA, Lewis DA, Bahmanyar S, Goldgaber D, Gajdusek DC, Young WG, Morrison JH, Wilson MC., 1988, Differential regulation of amyloid-beta-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease. Proc. Natl. Acad. Sci. USA, 85(4):1297-301.
45. Hohn A, Leibrock J, Bailey K, Barde YA., 1990, Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature, 344(6264):339-41.
46. Howells DW, Porritt MJ, Wong JY, Batchelor PE, Kalnins R, Hughes AJ, Donnan GA., 2000, Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra. Exp. Neurol., 166(1):127-35.
47. Hurelbrink CB, Armstrong RJ, Luheshi LM, Dunnett SB, Rosser AE, Barker RA., 2001, Death of dopaminergic neurons in vitro and in nigral grafts: reevaluating the role of caspase activation. Exp. Neurol, 171(1):46-58.
48. Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM., 1991, BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature, 350(6315):230-2.
49. Ip NY, Ibáñez CF, Nye SH, McClain J, Jones PF, Gies DR, Belluscio L, Le Beau MM, Espinosa R 3rd, Squinto SP, 1992, Mammalian neurotrophin-4: structure, chromosomal localization, tissue distribution, and receptor specificity. Proc. Natl. Acad. Sci. USA, 89(7):3060-4.
50. Ivins KJ, Bui ET, Cotman CW., 1999, Beta-amyloid induces local neurite degeneration in cultured hippocampal neurons: evidence for neuritic apoptosis. Neurobiol. Dis., 5(5):365-78.
51. Jänicke RU, Sprengart ML, Wati MR, Porter AG., 1998a, Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem., 273(16):9357-60.
52. Jänicke RU, Ng P, Sprengart ML, Porter AG., 1998b, Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis., J. Biol. Chem., 273(25):15540-5.
53. Jellinger KA., 2000, Cell death mechanisms in Parkinson's disease., J. Neural. Transm., 107(1):1-29.
54. Kerr JF, Wyllie AH, Currie AR., 1972, Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26(4):239-57.
55. Kahns S, Lykkebo S, Jakobsen LD, Nielsen MS, Jensen PH., 2002, Caspase-mediated parkin cleavage in apoptotic cell death. J. Biol. Chem., 277(18):15303-8.
56. Kirik D, Georgievska B, Rosenblad C, Björklund A., 2001, Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease., Eur. J. Neurosci., 13(8):1589-99.
57. Kitamura Y, Shimohama S, Kamoshima W, Ota T, Matsuoka Y, Nomura Y, Smith MA, Perry G, Whitehouse PJ, Taniguchi T., 1998, Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and Cpp32, in Alzheimer's disease. Brain Res., 780(2):260-9.
58. Kordower JH, Palfi S, Chen EY, Ma SY, Sendera T, Cochran EJ, Cochran EJ, Mufson EJ, Penn R, Goetz CG, Comella CD., 1999, Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease. Ann. Neurol., 46(3):419-24.
59. Kruman II, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L, Mattson MP., 2000, Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J. Neurosci., 20(18):6920-6.
60. Kuwana T, Mackey MR, Perkins G, Ellisman MH, Latterich M, Schneiter R, Green DR, Newmeyer DD., 2002, Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell., 111(3):331-42.
61. Lang AE, Gill S, Patel NK, Lozano A, Nutt JG, Penn R, Brooks DJ, Hotton G, Moro E, Heywood P, Brodsky MA, Burchiel K, Kelly P, Dalvi A, Scott B, Stacy M, Turner D, Wooten VG, Elias WJ, Laws ER, Dhawan V, Stoessl AJ, Matcham J, Coffey RJ, Traub M., 2006, Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease., Ann. Neurol., 59(3):459-66.
62. Laske C, Stellos K, Hoffmann N, Stransky E, Straten G, Eschweiler GW, Leyhe T., 2010, Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients. Int. J. Neuropsychopharmacol., 22:1-6.
63. Levi-Montalcini R, Hamburger V., 1951, Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J. Exp. Zool., 116(2):321-61.
64. Levivier M, Przedborski S, Bencsics C, Kang UJ., 1995, Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease. J. Neurosci., 15(12):7810-20.
65. Li C, Brake WG, Romeo RD, Dunlop JC, Gordon M, Buzescu R, Magarinos AM, Allen PB, Greengard P, Luine V, McEwen BS., 2004, Estrogen alters hippocampal dendritic spine shape and enhances synaptic protein immunoreactivity and spatial memory in female mice. Proc. Natl. Acad. Sci. USA, 101(7):2185-90.
66. Li R, Shen Y, Yang LB, Lue LF, Finch C, Rogers J., 2000, Estrogen enhances uptake of amyloid beta-protein by microglia derived from the human cortex. J. Neurochem., 75(4):1447-54.
67. Liang XB, Liu XY, Li FQ, Luo Y, Lu J, Zhang WM, Wang XM, Han JS., 2002, Long-term high-frequency electro-acupuncture stimulation prevents neuronal degeneration and up-regulates BDNF mRNA in the substantia nigra and ventral tegmental area following medial forebrain bundle axotomy. Brain Res. Mol. Brain Res., 108(1-2):51-9.
68. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F., 1993, GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science, 260(5111):1130-2.
69. Liu X, Kim CN, Yang J, Jemmerson R, Wang X., 1996, Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell., 86(1):147-57.
70. Luetjens CM, Lankiewicz S, Bui NT, Krohn AJ, Poppe M, Prehn JH., 2001, Up-regulation of Bcl-xL in response to subtoxic beta-amyloid: role in neuronal resistance against apoptotic and oxidative injury. Neuroscience., 102(1):139-50.
71. Maisonpierre PC, Belluscio L, Squinto S, Ip NY, Furth ME, Lindsay RM, Yancopoulos GD., 1990, Neurotrophin-3: a neurotrophic factor related to NGF and BDNF. Science. 1990, 247(4949 Pt 1):1446-51.
72. Massa V, Savery D, Ybot-Gonzalez P, Ferraro E, Rongvaux A, Cecconi F, Flavell R, Greene ND, Copp AJ., 2009, Apoptosis is not required for mammalian neural tube closure. Proc. Natl. Acad. Sci. USA, 106(20):8233-8.
73. Mayeux R, Marder K, Cote LJ, Denaro J, Hemenegildo N, Mejia H, Tang MX, Lantigua R, Wilder D, Gurland B., 1995, The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am. J. Epidemiol., 142(8):820-7.
74. Middleton G, Pinon LG, Wyatt S, Davies AM. Bcl-2 accelerates the maturation of early sensory neurons. Journal of Neuroscience, 1998, 18(9), 3344-3350.
75. Middleton G, Wyatt S, Cox A, Korsmeyer SJ, Davies AM. Differences in Bcl-2 and Bax-independent function in regulating apoptosis in sensory neuron populations. European Journal of Neuroscience, 2000, 12(3), 819-827.
76. Middleton G, Wyatt S, Ninkina NN, Davies AM., 2001, Reciprocal developmental changes in the roles of Bcl-w and Bcl-xL in regulating sensory neuron survival. Development, 128, 447-457.
77. Middleton GH, 2004, Death of neurons during development. Encyclopedia of Neuroscience 3rd edition: ISBN 0-444-51432-5.
78. Miller MM, Monjan AA, Buckholtz NS., 2001, Estrogen replacement therapy for the potential treatment or prevention of Alzheimer's disease. Ann. N. Y. Acad. Sci., 949:223-34.
79. Mizuno Y, Mochizuki H, Sugita Y, Goto K., 1998, Apoptosis in neurodegenerative disorders. Intern. Med., 37(2):192-3.
80. Mufson EJ, Conner JM, Kordower JH., 1995, Nerve growth factor in Alzheimer's disease: defective retrograde transport to nucleus basalis., Neuroreport., 6(7):1063-6.
81. Murer MG, Yan Q, Raisman-Vozari R., 2001, Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog. Neurobiol., 63(1):71-124.
82. Nakagawara A, Nakamura Y, Ikeda H, Hiwasa T, Kuida K, Su MS, Zhao H, Cnaan A, Sakiyama S., 1997, High levels of expression and nuclear localization of interleukin-1 beta converting enzyme (ICE) and Cpp32 in favorable human neuroblastomas. Cancer Res., 57(20):4578-84.
83. Nixon RA., 2006, Autophagy in neurodegenerative disease: friend, foe or turncoat? Trends Neurosci., 29(9):528-35.
84. Nordeen EJ, Nordeen KW, Sengelaub DR, Arnold AP., 1985, Androgens prevent normally occurring cell death in a sexually dimorphic spinal nucleus. Science., 229(4714):671-3.
85. Nuñez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ., 1990, Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J. Immunol. 1990, 144(9):3602-10.
86. Nutt JG, Burchiel KJ, Comella CL, Jankovic J, Lang AE, Laws ER Jr, Lozano AM, Penn RD, Simpson RK Jr, Stacy M, Wooten GF; ICV GDNF Study Group., 2003, Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology., 60(1):69-73.
87. O'Bryant SE, Hobson VL, Hall JR, Barber RC, Zhang S, Johnson L, Diaz-Arrastia R., 2011, Serum Brain-Derived Neurotrophic Factor Levels Are Specifically Associated with Memory Performance among Alzheimer's Disease Cases. Dement. Geriatr. Cogn. Disord., 31(1):31-6.
88. O'Leary DD, Fawcett JW, Cowan WM., 1986, Topographic targeting errors in the retinocollicular projection and their elimination by selective ganglion cell death. J. Neurosci., 6(12):3692-705.
89. Oldreive CE, Doherty GH., 2010, Effects of tumour necrosis factor-alpha on developing cerebellar granule and Purkinje neurons in vitro. J. Mol. Neurosci., 42(1):44-52.
90. Olson L, Nordberg A, von Holst H, Bäckman L, Ebendal T, Alafuzoff I, Amberla K, Hartvig P, Herlitz A, Lilja A., 1992, Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report)., J. Neural. Transm. Park Dis. Dement. Sect., 4(1):79-95.
91. Oppenheim RW., 1991, Cell death during development of the nervous system. Annu. Rev. Neurosci., 14:453-501.
92. Oppenheim RW, Flavell RA, Vinsant S, Prevette D, Kuan CY, Rakic P., 2001, Programmed cell death of developing mammalian neurons after genetic deletion of caspases. J. Neurosci., 21(13):4752-60.
93. Otani H, Erdos M, Leonard WJ., 1993, Tyrosine kinase(s) regulate apoptosis and bcl-2 expression in a growth factor-dependent cell line. J. Biol. Chem., 268(30):22733-6.
94. Paradis E, Douillard H, Koutroumanis M, Goodyer C, LeBlanc A., 1996, Amyloid beta peptide of Alzheimer's disease downregulates Bcl-2 and upregulates bax expression in human neurons. J. Neurosci., 16(23):7533-9.
95. Parain K, Murer MG, Yan Q, Faucheux B, Agid Y, Hirsch E, Raisman-Vozari R., 1999, Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra. Neuroreport., 10(3):557-61.
96. Park HJ, Lim S, Joo WS, Yin CS, Lee HS, Lee HJ, Seo JC, Leem K, Son YS, Kim YJ, Kim CJ, Kim YS, Chung JH., 2003, Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model. Exp. Neurol., 180(1):93-8.
97. Parsian A, Sinha R, Racette B, Zhao JH, Perlmutter JS., 2004, Association of a variation in the promoter region of the brain-derived neurotrophic factor gene with familial Parkinson's disease. Parkinsonism Relat. Disord., 10(4):213-9.
98. Perry EK, Perry RH, BlessedG, Tomlinson BE., 1978, Changes in brain cholinesterases in senile dementia of Alzheimer type., Neuropathol. Appl. Neurobiol. 4: 273-277.
99. Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH., 1978, Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. Med. J. 2: 1457-1459.
100. Pinon LG, Middleton G, Davies AM., 1997, Bcl-2 is required for cranial sensory neuron survival at defined stages of embryonic development. Development, 124(20), 4173-4178
101. Raoul C, Henderson CE, Pettmann B., 1999, Programmed cell death of embryonic motoneurons triggered through the Fas death receptor. J. Cell Biol., 1999, 147(5):1049-62.
102. Rosenthal A, Goeddel DV, Nguyen T, Lewis M, Shih A, Laramee GR, Nikolics K, Winslow JW., 1990, Primary structure and biological activity of a novel human neurotrophic factor. Neuron., 4(5):767-73.
103. Satou T, Cummings BJ, Cotman CW., 1995, Immunoreactivity for Bcl-2 protein within neurons in the Alzheimer's disease brain increases with disease severity. Brain Res., 697(1-2):35-43.
104. Sawada H, Ibi M, Kihara T, Urushitani M, Honda K, Nakanishi M, Akaike A, Shimohama S., 2000, Mechanisms of antiapoptotic effects of estrogens in nigral dopaminergic neurons. FASEB J., 14(9):1202-14.
105. Schierle GS, Hansson O, Leist M, Nicotera P, Widner H, Brundin P., 1999, Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nat. Med., 5(1):97-100.
106. Siegel GJ, Chauhan NB., 2000, Neurotrophic factors in Alzheimer's and Parkinson's disease brain., Brain Res. Brain Res. Rev., 33(2-3):199-227.
107. Stadelmann C, Brück W, Bancher C, Jellinger K, Lassmann H., 1998, Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis. J. Neuropathol. Exp. Neurol., 57(5):456-64.
108. Stone DJ, Rozovsky I, Morgan TE, Anderson CP, Finch CE., 1998, Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimer's disease., J. Neurosci., 18(9):3180-5.
109. Su JH, Satou T, Anderson AJ, Cotman CW., 1996, Up-regulation of Bcl-2 is associated with neuronal DNA damage in Alzheimer's disease. Neuroreport., 7(2):437-40.
110. Su JH, Deng G, Cotman CW., 1997, Bax protein expression is increased in Alzheimer's brain: correlations with DNA damage, Bcl-2 expression, and brain pathology. J. Neuropathol. Exp. Neurol., 56(1):86-93.
111. Tang M, Abplanalp W, Ayres S, Subbiah MT., 1996, Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation. Metabolism., 45(4):411-4.
112. Tomac A, Lindqvist E, Lin LF, Ogren SO, Young D, Hoffer BJ, Olson L., 1995, Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature., 373(6512):335-9.
113. Tompkins MM, Basgall EJ, Zamrini E, Hill WD., 1997, Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. Am. J. Pathol., 150(1):119-31.
114. Troy CM, Rabacchi SA, Friedman WJ, Frappier TF, Brown K, Shelanski ML., 2000, Caspase-2 mediates neuronal cell death induced by beta-amyloid. J. Neurosci., 20(4): 1386-92.
115. Tsujimoto Y, Croce CM., 1986, Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA, 83(14):5214-8.
116. Tsukahara T, Takeda M, Shimohama S, Ohara O, Hashimoto N., 1995, Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced parkinsonism in monkeys. Neurosurgery., 37(4):733-9
117. Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM., 2003, Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity., Am. J. Epidemiol., 157(11):1015-22.
118. Vila M, Jackson-Lewis V, Vukosavic S, Djaldetti R, Liberatore G, Offen D, Korsmeyer SJ, Przedborski S., 2001, Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson's disease. Proc. Natl. Acad. Sci. USA, 98(5):2837-42.
119. Voyvodic JT., 1996, Cell death in cortical development: How much? Why? So what? Neuron., 16(4):693-6.
120. Weil M, Jacobson MD, Raff MC., 1997, Is programmed cell death required for neural tube closure? Curr. Biol., 7(4):281-4.
121. Williams LR, Varon S, Peterson GM, Wictorin K, Fischer W, Bjorklund A, Gage FH., 1986, Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc. Natl. Acad. Sci. USA, 83(23):9231-5.
122. Willis SN, Fletcher JI, Kaufmann T, van Delft MF, Chen L, Czabotar PE, Ierino H, Lee EF, Fairlie WD, Bouillet P, Strasser A, Kluck RM, Adams JM, Huang DC., 2007, Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science., 315(5813):856-9.
123. Xu H, Gouras GK, Greenfield JP, Vincent B, Naslund J, Mazzarelli L, Fried G, Jovanovic JN, Seeger M, Relkin NR, Liao F, Checler F, Buxbaum JD, Chait BT, Thinakaran G, Sisodia SS, Wang R, Greengard P, Gandy S., 1998, Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat. Med., 4(4):447-51.
124. Yang L, Sugama S, Mischak RP, Kiaei M, Bizat N, Brouillet E, Joh TH, Beal MF., 2004, A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo. Neurobiol. Dis., 17(2):250-9.
125. Yurek DM, Hipkens SB, Wiegand SJ, Altar CA., 1998, Optimal effectiveness of BDNF for fetal nigral transplants coincides with the ontogenic appearance of BDNF in the striatum., J. Neurosci., 18(15):6040-7.
126. Zhivotovsky B, Samali A, Gahm A, Orrenius S., 1999, Caspases: their intracellular localization and translocation during apoptosis. Cell Death Differ., 6(7):644-51.